Prior to releasing a genetically modified plant (GMP) into the environment and placing it on the market in the European Union, an environmental risk assessment has to be performed according to Directive 2001/18/EC. Based on the results of a previous project conducted from 2012 to 2016 (for more information, see the project description and the publication of Jänsch et al. 2018) this project has two aims: (1) The previously developed method uses the black fungus gnat Bradysia impatiens (Diptera). However, at Central European crop sites, the species Lycoriella castanescens is more widely distributed. Therefore, the method will be adapted to include this ecologically more relevant species. (2) The modified test method will be used to study the effects of genetically modified maize material on B. impatiens and L. castanescens to verify and confirm results obtained in the previous project. Depending on the obtained results, an interlaboratory comparison test with one or both species will be conducted. Subsequently, the improved test method will be assessed in an international ringtest. Thus, the final aim of this work is to prepare a draft test guideline, probably according to OECD requirements.
ECT Oekotoxikologie GmbH is a privately owned enterprise that was founded in 1993.
In compliance with Good Laboratory Practice (GLP), we perform standardised ecotoxicological tests in the laboratory as well as at semi-field and field level.
- New publication: Compartment‐specific screening tools for persistence – potential role and application in the regulatory context
- Conference ‘New approaches for prioritisation and assessment of the risks of pharmaceuticals in the environment’
- Presentation of the iPiE project at the SETAC Europe meeting
Find us at
ECT Oekotoxikologie GmbH
Böttgerstraße 2 – 14
65439 Flörsheim am Main
Phone: +49 6145 9564-0
Fax: +49 6145 9564-99